Kidney Failure, Chronic Clinical Trial
— KITEOfficial title:
Impact of a Simple Clinical Tool for Increasing Enrollment on a Kidney Transplant Waiting List for Patients Aged Over 70 and Initiating Dialysis
Verified date | February 2021 |
Source | Centre Hospitalier Universitaire de Nimes |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main objective of this study is to show that the systematic use of a prognostic score as early as possible after the initiation of dialysis in patients over 70 years of age and with a good prognosis at 3 years of dialysis results in an increase in the number of entries on a kidney transplant waiting list at 12 months after the initiation of dialysis. This prospective assessment is carried out as part of a historico-prospective before-after study in parallel with a survey of changes in national practices over the same time period via a here-elsewhere type study. Historical data (i.e the. "before" period) will include incident dialysis cases during the calendar years 2013, 2014 and 2015 before the start of the prospective phase (i.e. "after" period, which is represented by the current declaration); since a preliminary study demonstrated that the data are comparable from 2011 to 2013, we will use the average of data thus obtained. Historical data will be retrieved from the REIN (The French Renal Epidemiology and Information Network) registry data and will be validated by investigators at each center.
Status | Terminated |
Enrollment | 46 |
Est. completion date | March 2, 2020 |
Est. primary completion date | March 2, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 70 Years to 84 Years |
Eligibility | Inclusion Criteria: - The patient must have given his/her informed and signed consent - The patient must be insured or beneficiary of a health insurance plan - The patient is available for 12 months of follow-up - Patient initiating chronic dialysis (incident cases) - Patients with a 3 year prognostic mortality score less than (<) 10 points (Dusseux et al. 2015) Exclusion Criteria: - The patient is participating in another interventional study - The patient is in an exclusion period determined by a previous study - The patient is under judicial protection, under tutorship or curatorship - The patient refuses to sign the consent - It is impossible to correctly inform the patient - Patient on preemptive kidney transplant waiting list (before the initiation of a chronic dialysis program) |
Country | Name | City | State |
---|---|---|---|
France | Clinique Claude Bernard | Albi | |
France | AIDER - Unité de Dialyse d'Alès | Alès | |
France | CH d'Auch | Auch | |
France | Centre d'Hemodialyse Languedoc Méditérranéen | Béziers | |
France | Medipole Grand Sud St Roch | Cabestany | |
France | CH de Cahors | Cahors | |
France | NephroCare | Castelnau le Lez | |
France | CH de Carcassonne | Cité De Carcassonne | |
France | AAIR Midi-Pyrénées | Colomiers | |
France | Centre Hospitalier Intercommunal du Val d'Ariège | Foix Cedex | |
France | Clinique du Pont de Chaume | Montauban | |
France | AIDER de Montpellier | Montpellier | |
France | CHRU de Montpellier - Hôpital Lapeyronie | Montpellier | |
France | Clinique de l'Occitanie | Muret Cedex | |
France | Polyclinique Le Languedoc | Narbonne | |
France | Gardialyse | Nîmes | |
France | CHRU de Nîmes - Hôpital Universitaire Carémeau | Nîmes Cedex 09 | |
France | AIDER - Unité de Dialyse de Nîmes | Nîmes Cedex 9 | |
France | CH de Perpignan - Hôpital Saint Jean | Perpignan | |
France | Centre Hospitalier Jacques Puel | Rodez | |
France | CH de Bigorre | Tarbes Cedex 9 | |
France | Clinique Néphrologique Saint-Exupéry | Toulouse Cedex 4 | |
France | CHRU de Toulouse - Hôpital de Rangueil | Toulouse Cedex 9 | |
France | CHRU de Toulouse - Hôpital Larrey | Toulouse Cedex 9 | |
France | CHRU de Toulouse - Hôptal Casselardit | Toulouse Cedex 9 |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nimes |
France,
Dusseux E, Albano L, Fafin C, Hourmant M, Guérin O, Couchoud C, Moranne O. A simple clinical tool to inform the decision-making process to refer elderly incident dialysis patients for kidney transplant evaluation. Kidney Int. 2015 Jul;88(1):121-9. doi: 10.1038/ki.2015.25. Epub 2015 Feb 11. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The % number of registrants on the kidney transplant waiting list | 12 months | ||
Secondary | Delay between the initiation of dialysis and inclusion on the kidney transplant waiting list | This outcome integrates the the duration of initial assessment and is measured by the difference between the start and end dates of the pre-transplant assessment. | 12 months | |
Secondary | The number of refusals by patients for registration on the kidney transplant waiting list | 12 months | ||
Secondary | In case of patient refusal for registration, the reasons why (qualitative approach) | 12 months | ||
Secondary | The number of cases where there is a medical contra-indication for registration on the kidney transplant waiting list | 12 months | ||
Secondary | In case of a medical contra-indication for registration on the kidney transplant waiting list, the cause (qualitative approach) | 12 months | ||
Secondary | The cost of care associated with dialysis patients and dialysed-and-then-transplanted patients will be estimated from the point of view of the French health insurance system | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03246984 -
VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ
|
N/A | |
Completed |
NCT02922361 -
Spending and Outcomes for Complex Medicare Advantage Patients
|
||
Completed |
NCT02235571 -
iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
|
N/A | |
Completed |
NCT01922843 -
A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis
|
Phase 2 | |
Completed |
NCT01930396 -
Use of Tinzaparin for Anticoagulation in Hemodialysis
|
Phase 4 | |
Completed |
NCT01933789 -
Improving Communication About Serious Illness
|
N/A | |
Not yet recruiting |
NCT01674660 -
Factors Associated With Interdialytic Blood Pressure Variability in Maintenance Hemodialysis Patients
|
N/A | |
Not yet recruiting |
NCT01157260 -
The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT01209403 -
Insulin-like Growth Factor (IGF-I) in Hemodialysis Patients
|
Phase 4 | |
Completed |
NCT00753116 -
Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension
|
Phase 1 | |
Recruiting |
NCT00532688 -
N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
|
Phase 2/Phase 3 | |
Completed |
NCT00534144 -
Comparison Between Effects of Two Iron Preparations on Protein in the Urine
|
Phase 1 | |
Completed |
NCT00528788 -
How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
|
Phase 4 | |
Completed |
NCT00382044 -
Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
|
N/A | |
Completed |
NCT00226902 -
Vascular Reactivity in Kidney Disease Patients
|
N/A | |
Recruiting |
NCT00235287 -
Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT00224081 -
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
|
Phase 4 | |
Completed |
NCT00071214 -
Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis
|
Phase 3 | |
Completed |
NCT00049907 -
Cardiac and Renal Disease Study (CARDS)
|
N/A | |
Completed |
NCT00006297 -
Risk Factors for CV Disease in a Dialysis Cohort
|
N/A |